2-(Tributylstannyl)pyrimidine
Product Information
Molecular Formula
C16H30N2Sn
Molecular Weight
369.13
Description
2-(Tributylstannyl)pyrimidine is an organotin compound used in Stille coupling reaction. This can be used as one of the precursors in the synthesis of 2-aminopyridine oxazolidinones as potent and selective tankyrase (TNKS) inhibitors and the synthesis of canagliflozin, a novel inhibitor for sodium-dependent glucose cotransporter.It can also be used in the preparation of various (2-pyrimidyl)silanes.
Synonyms
tributyl(2-pyrimidinyl)stannane; tributyl(pyrimidin-2-yl)stannane
IUPAC Name
tributyl(pyrimidin-2-yl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1=NC=CC=N1
InChI
InChI=1S/C4H3N2.3C4H9.Sn/c1-2-5-4-6-3-1;3*1-3-4-2;/h1-3H;3*1,3-4H2,2H3;
InChI Key
WTFFOOAJSDVASL-UHFFFAOYSA-N
Boiling Point
381.2 °C at 760 mmHg
Flash Point
Not applicable
Purity
95 %
Density
1.164 g/mL at 25 °C
Refractive Index
n20/D 1.512
LogP
4.53270
Safety Information
Hazards
H301 - H312 - H315 - H319 - H372 - H410
Precautionary Statement
P260, P264, P270, P273, P280, P301+P310, P302+P352, P305+P351+P338, P312, P314, P321, P322, P330, P332+P313, P337+P313, P362, P363, P391, P405, and P501
Signal Word
Danger
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
10
Exact Mass
370.143102 g/mol
Monoisotopic Mass
370.143102 g/mol
Topological Polar Surface Area
25.8Ų
Heavy Atom Count
19
Formal Charge
0
Complexity
193
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022053541-A1 | Compounds for use as appetite suppressant | 2020-09-10 |
| WO-2021263278-A1 | Rev-erb agonists for the treatment of th17-mediated inflammatory disorders | 2020-06-23 |
| WO-2021226206-A2 | Cannabinoid receptor type 2 (cb2) modulators and uses thereof | 2020-05-05 |
| WO-2021222363-A1 | Cycloalkyl pyrimidines as ferroportin inhibitors | 2020-04-28 |
| WO-2021222483-A1 | Methods of use for pyrimidines as ferroportin inhibitors | 2020-04-28 |
| WO-2021195781-A1 | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use | 2020-04-01 |
| WO-2021195782-A1 | Methods of using myt1 inhibitors | 2020-04-01 |
| WO-2021178488-A1 | Eif4e inhibitors and uses thereof | 2020-03-03 |
| WO-2021117846-A1 | Compound serving as pdgf receptor kinase inhibitor, and composition | 2019-12-13 |
| TW-202136234-A | Compounds and compositions as inhibitors of PDGF receptor kinase | 2019-12-13 |
